Novartis Bets Big on Cardiovascular Biotech With $3bn Anthos Deal

Swiss pharmaceutical giant Novartis has announced an agreement to acquire Anthos Therapeutics from Blackstone Life Sciences in a deal valued at up to $3.1 Billion. The deal includes a $925 Million upfront payment, with additional payouts tied to future regulatory and commercial success. Investment Implications For Novartis: This move allows Novartis to regain abelacimab, a […]

Cancer treatment could identify patients most likely to respond to cancer drugs

Pharma Analysis Doctor and Patient

Scientists from the Cancer Research UK Scotland Institute and Memorial Sloan Kettering Cancer Centre have discovered a cancer treatment that can identify patients who are more likely to respond to cancer drugs. Funded by Cancer Research UK and published in Nature Cancer, the study reveals new ways to identify patients who could benefit most from […]

en_USEnglish